1 |
Oishi T, Fujieda M, Shiraishi T, Ono M, Inoue K, Takahashi A, et al. Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm. Circ J 2008;72:850-2
DOI
ScienceOn
|
2 |
Kim HR, Lee MK, Park AJ. The -308 and -238 Polymorphisms of the TNF-alpha promoter gene in type 2 diabetes mellitus. Korean J Lab Med 2006;26:58-63
DOI
PUBMED
ScienceOn
|
3 |
Chang RK. Epidemiologic characteristics of children hospitalized for Kawasaki disease in California. Pediatr Infect Dis J 2002;21:1150-5
DOI
PUBMED
ScienceOn
|
4 |
Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Storoupe C, Shike H, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res 2001;49:686-90
DOI
ScienceOn
|
5 |
Ouchi K, Suzuki Y, Shirakawa T, Kishi F. Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis 2003;187:326-9
DOI
ScienceOn
|
6 |
Komatsu H, Fujisawa T. Kawasaki disease and infection. Nippon Rinsho 2008;66:278-82
PUBMED
|
7 |
Abe J. Immunological aspects of Kawasaki disease. Nippon Rinsho 2008;66:267-71
PUBMED
|
8 |
Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003;44:1021-6
PUBMED
ScienceOn
|
9 |
Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000;43:129-34
DOI
ScienceOn
|
10 |
Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561-8
DOI
ScienceOn
|
11 |
Taylor JG, Choi EH, Foster CB, Chanock SJ. Using genetic variation to study human disease. Trends Mol Med 2001; 7:507-12
DOI
ScienceOn
|
12 |
Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994;13:704-8
DOI
PUBMED
ScienceOn
|
13 |
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9
DOI
ScienceOn
|
14 |
Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, et al. The correlation between Kawasaki disease and polymorphisms of tumor necrosis factor alpha and interleukin-10 gene promoter. Zhonghua Er Ke Za Zhi 2003;41:598-602
PUBMED
|
15 |
Hui-Yuen JS, Duong TT, Yeung RS. TNF-alpha is neces sary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006 May 15;176:6294-301
|
16 |
Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, et al. Kawasaki disease in families. Pediatrics 1989;84:666-9
PUBMED
ScienceOn
|
17 |
Curtis N, Levin M. Kawasaki disease thirty years on. Curr Opin Pediatr 1998;10:24-33
DOI
ScienceOn
|
18 |
Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353
PUBMED
|
19 |
Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80
PUBMED
ScienceOn
|
20 |
Belay ED, Holman RC, Clarke MJ, Destefano F, Shahriari A, Davis RL, et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J 2000;19:828-32
DOI
ScienceOn
|
21 |
Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am 1999;46:313-29
DOI
ScienceOn
|